A perspective on Alzheimer's disease: exploring the potential of terminal/paradoxical lucidity and psychedelics

Mol Neurodegener. 2024 Oct 12;19(1):72. doi: 10.1186/s13024-024-00761-5.

Authors

Cong Lin¹, Xiubo Du², Xiaohui Wang³

Affiliations

¹ Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
² College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, 518060, China.
³ Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China. xiaohui.wang@ciac.ac.cn.

PMID: 39396013
DOI: 10.1186/s13024-024-00761-5

No abstract available

Publication types

Editorial

MeSH terms

Alzheimer Disease* / drug therapy
Hallucinogens* / pharmacology
Humans

Substances

Hallucinogens

Grants and funding

T2241028/National Natural Science Foundation of China